Menu Search
Equities

Resmed Inc

RMD:ASX

Resmed Inc

Actions
  • Price (AUD)31.95
  • Today's Change0.17 / 0.53%
  • Shares traded746.89k
  • 1 Year change-3.88%
  • Beta--
Data delayed at least 20 minutes, as of Jun 07 2024 07:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		RMD:NYQ since
announced		Transaction
value
KC Machine LLCDeal completed29 Sep 202329 Sep 2023Deal completed40.56%2.60m
Somnoware Healthcare Systems IncDeal completed05 Jul 202305 Jul 2023Deal completed-1.74%--
Data delayed at least 15 minutes, as of Jun 07 2024 21:10 BST.

Institutional shareholders

2.81%Per cent of shares held by top holders
HolderShares% Held
Vanguard Investments Australia Ltd.as of 30 Apr 20248.72m0.59%
First Sentier Investors (Hong Kong) Ltd.as of 29 Feb 20247.16m0.49%
Schroder Investment Management (Singapore) Ltd.as of 29 Feb 20245.59m0.38%
First Sentier Investors (Australia) IM Ltd.as of 29 Feb 20244.36m0.30%
FIL Investment Management (Singapore) Ltd.as of 30 Apr 20243.53m0.24%
BetaShares Capital Ltd.as of 31 May 20243.23m0.22%
Russell Investment Management Ltd.as of 28 Mar 20242.32m0.16%
FIL Investment Management (Australia) Ltd.as of 30 Apr 20242.27m0.15%
Veritas Asset Management LLPas of 30 Sep 20232.15m0.15%
Abrdn Asia Ltd.as of 06 Jun 20242.05m0.14%
More ▼
Data from 31 Mar 2024 - 06 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.